QurAlis Corporation, a biotech company focused on developing precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurological diseases, raised a seed extension that brings the total funding to date to $5.5 million. BioInnovation Capital and Viva Biotech Limited join existing biotech investors MP Healthcare
Cota Inc., a healthcare evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV), with major participation by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated
Single-cell DNA analysis company Mission Bio, Inc. announced it has secured $10 million in Series A funding led by Mayfield Fund. Mission Bio’s Tapestri platform is a scalable, highly sensitive, and customizable precision genomics platform that addresses current industry shortcomings with throughput up to 10,000